Marshall Hayward
Oprichter bij JUPITER NEUROSCIENCES, INC.
Profiel
Marshall Hayward is the founder of Jupiter Neurosciences, Inc. founded in 2015, where he holds the title of Director & Chief Scientific Officer.
He is currently the Managing Member at Dr. Hayward Associates LLC since 2013.
In his former positions, he was the Director, VP-Analgesics Research & Development at Smithkline Beecham Plc, Director & Vice President-Analgesics Research at GSK Plc, Director-New Business Development at Rhodia Pharma Solutions Ltd., Chief Scientific Officer & VP-Business Development at EffRx, Inc., and Principal at Wyeth Pharmaceuticals LLC.
He was also the Chief Scientific Officer at EffRx Pharmaceuticals SA from 2002 to 2013.
Additionally, he held the title of Vice President-Business Development at Hurley Consulting Associates.
Dr. Hayward received his doctorate degree from the University of Illinois in 1982 and his undergraduate degree from the University of Michigan in 1977.
Actieve functies van Marshall Hayward
Bedrijven | Functie | Begin |
---|---|---|
JUPITER NEUROSCIENCES, INC. | Oprichter | 01-06-2015 |
Marshall Hayward Associates LLC | Corporate Officer/Principal | 01-05-2013 |
Eerdere bekende functies van Marshall Hayward
Bedrijven | Functie | Einde |
---|---|---|
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 01-05-2013 |
EffRx, Inc.
EffRx, Inc. Pharmaceuticals: MajorHealth Technology EffRx Inc. is an innovative company that exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential and once developed partner these products with established pharmaceutical companies. Their goal is to become a global provider of products, based on alternative drug delivery technologies for both the prescription and OTC markets, by applying their technologies to well established proven compounds and developing reformulated products with reduced gastrointestinal side effects, better absorption and faster onset of action. Thereby generating better products for patients in a cost effective manner. The primary focus and the leading project is to introduce EX101 (a proprietary effervescent alendronate) in markets worldwide, capitalizing on the unique intellectual property position of the combined EffRx patents and the patents exclusively licensed from Merck & Co. | Hoofd Techniek/Wetenschap/O&O | 10-06-2011 |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
Rhodia Pharma Solutions Ltd.
Rhodia Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Rhodia Pharma Solutions Ltd. manufactures pharmaceutical products. The company was founded on August 26, 1965 and is headquartered in Watford, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Marshall Hayward
University of Illinois | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GSK PLC | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
EffRx, Inc.
EffRx, Inc. Pharmaceuticals: MajorHealth Technology EffRx Inc. is an innovative company that exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential and once developed partner these products with established pharmaceutical companies. Their goal is to become a global provider of products, based on alternative drug delivery technologies for both the prescription and OTC markets, by applying their technologies to well established proven compounds and developing reformulated products with reduced gastrointestinal side effects, better absorption and faster onset of action. Thereby generating better products for patients in a cost effective manner. The primary focus and the leading project is to introduce EX101 (a proprietary effervescent alendronate) in markets worldwide, capitalizing on the unique intellectual property position of the combined EffRx patents and the patents exclusively licensed from Merck & Co. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Health Technology |
Rhodia Pharma Solutions Ltd.
Rhodia Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Rhodia Pharma Solutions Ltd. manufactures pharmaceutical products. The company was founded on August 26, 1965 and is headquartered in Watford, the United Kingdom. | Health Technology |
Hurley Consulting Associates | |
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
Marshall Hayward Associates LLC |